Switch to:

10x Genomics EV-to-Revenue

: 29.32 (As of Today)
View and export this data going back to 2019. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, 10x Genomics's enterprise value is $7,747.9 Mil. 10x Genomics's Revenue for the trailing twelve months (TTM) ended in Mar. 2020 was $264.2 Mil. Therefore, 10x Genomics's EV-to-Revenue for today is 29.32.

NAS:TXG' s EV-to-Revenue Range Over the Past 10 Years
Min: 4.7   Med: 24.05   Max: 37.8
Current: 29.31

4.7
37.8

During the past 3 years, the highest EV-to-Revenue of 10x Genomics was 37.80. The lowest was 4.70. And the median was 24.05.

NAS:TXG's EV-to-Revenue is ranked lower than
95% of the 505 Companies
in the Healthcare Providers & Services industry.

( Industry Median: 1.98 vs. NAS:TXG: 29.31 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2020-06-01), 10x Genomics's stock price is $81.95. 10x Genomics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2020 was $4.22. Therefore, 10x Genomics's PS Ratio for today is 19.41.


10x Genomics EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

10x Genomics Annual Data
Dec17 Dec18 Dec19
EV-to-Revenue 0.00 0.00 28.24

10x Genomics Quarterly Data
Dec17 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 4.85 28.24 21.65

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


10x Genomics EV-to-Revenue Distribution

* The bar in red indicates where 10x Genomics's EV-to-Revenue falls into.



10x Genomics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

10x Genomics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=7747.871/264.22
=29.32

10x Genomics's current Enterprise Value is $7,747.9 Mil.
10x Genomics's Revenue for the trailing twelve months (TTM) ended in Mar. 2020 was 55.819 (Jun. 2019 ) + 61.207 (Sep. 2019 ) + 75.289 (Dec. 2019 ) + 71.905 (Mar. 2020 ) = $264.2 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


10x Genomics  (NAS:TXG) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

10x Genomics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=81.95/4.223
=19.41

10x Genomics's share price for today is $81.95.
10x Genomics's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2020 was 0.601 (Jun. 2019 ) + 2.097 (Sep. 2019 ) + 0.782 (Dec. 2019 ) + 0.743 (Mar. 2020 ) = $4.22.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


10x Genomics EV-to-Revenue Related Terms


10x Genomics EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)